The largest-selling HIV/AIDS drug, Viread is to be made available in India at the special price of $1 (Rs 45) per tablet, according to the manufacturer Gilead.// This announcement was made on Sunday.
Gilead has already entered into generic licensing deals with three Indian pharma majors - Emcure Pharmaceuticals, Hetero Drugs and Strides Arcolab - for the drug. The Indian firms will make generic versions of Viread and distribute it to 95 low-income countries around the world in a couple of months.
"Our endeavour is to provide the widest possible access to our drugs for HIV/AIDS patients. Gilead has devised a tiered product pricing based on a country's economic status and HIV prevalence," Gilead's senior vice-president Gregg Alton told IANS from San Jose, California.
More than 5.1 million people are believed to be infected with the HIV virus in India - the second largest number of infected people after South Africa.
"Viread will be available at $365 per year in India. For African countries where the economic status is lower, we have priced the drug at $203 per year, making it close to 37 cents a day for patients," he said.
There has been much speculation in recent months with claims that Viread had been overpriced, selling at $5,700 in the developed world.
Alton said, "That pricing information is inaccurate, while we have the right o protect our intellectual property in developed markets, our tiered pricingfor countries like India and Thailand will ensure that Viread will o well and provide better health status for patients."
Compared with generic versions currently available from pharma major Cipla, priced at over $1,200 per year, the new pricing is bound to come as a relief.
Viread (tenofovir disoproxil fumarate) is on its way to becoming the frontrunner drug across Europe for HIV/AIDS due to its low toxicity and resistance levels observed in patients. The tablet-a-day doPage: 1 2 3 Related medicine news :1
. FDA Approves New HIV Drug, Viread2
. Use Of Viread Spreads As New Anti-AIDS Site Is Launched3
. Impact of New Drug Retail Prices Soon: Paswan4
. Retail Clinics Becoming Increasingly Popular in US5
. Is Diabetes the Leading Cause of Kidney Failure in India
. AIDS Disaster in India is Imminent
. Indian Prime Minister has successful Knee Replacement Surgery8
. International community warns India on HIV situation9
. India takes on foot-and-mouth disease by vaccinating animals10
. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos11
. India to benefit from pharma companies move